INS and type 1 diabetes mellitus: Autoimmunity to insulin cannot be distinguished from antibodies to exogenous insulin appearing roughly two weeks after the first insulin injection in T1D cases, and therefore samples need to be tested in this window to be useful for diabetes classification or baseline monitoring in trials.